Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rappaport

Showing results (141-150 of 184) with videos related to

Pageof 19
Sort By:
Pain|May 17, 2014
Effect of variability in the 7-day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: an ACTTION studyJohn T Farrar, Andrea B Troxel, Kevin Haynes, et al.
Pain|October 20, 2009
Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendationsRobert H Dworkin, Dennis C Turk, Michael P McDermott, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 23, 2020
Twelve-Month Outcomes of Stand-Alone Excisional Goniotomy in Mild to Severe GlaucomaMohammed K ElMallah, John P Berdahl, Blake K Williamson, et al.
Journal for Immunotherapy of Cancer|August 22, 2020
Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunityJohn C Flickinger, Jagmohan Singh, Robert Carlson, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 26, 2021
A β-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal CancerJeffrey A Rappaport, Ariana A Entezari, Adi Caspi, et al.
The Journal of Pain|February 1, 2015
Quality of pain intensity assessment reporting: ACTTION systematic review and recommendationsShannon M Smith, Matthew Hunsinger, Andrew McKeown, et al.
Pain|September 19, 2012
Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: an ACTTION systematic reviewShannon M Smith, Daniel R Chang, Anthony Pereira, et al.
The Journal of Pain|February 10, 2015
Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic ReviewShannon M Smith, Florence Paillard, Andrew McKeown, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 5, 2014
Meta-analysis of assay sensitivity and study features in clinical trials of pharmacologic treatments for osteoarthritis painRobert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, et al.
Pain|November 27, 2013
Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendationsJennifer S Gewandter, Shannon M Smith, Andrew McKeown, et al.
Pageof 19

Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
Pain|May 17, 2014
Effect of variability in the 7-day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: an ACTTION studyJohn T Farrar, Andrea B Troxel, Kevin Haynes, et al.
Pain|October 20, 2009
Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendationsRobert H Dworkin, Dennis C Turk, Michael P McDermott, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 23, 2020
Twelve-Month Outcomes of Stand-Alone Excisional Goniotomy in Mild to Severe GlaucomaMohammed K ElMallah, John P Berdahl, Blake K Williamson, et al.
Journal for Immunotherapy of Cancer|August 22, 2020
Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunityJohn C Flickinger, Jagmohan Singh, Robert Carlson, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 26, 2021
A β-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal CancerJeffrey A Rappaport, Ariana A Entezari, Adi Caspi, et al.
The Journal of Pain|February 1, 2015
Quality of pain intensity assessment reporting: ACTTION systematic review and recommendationsShannon M Smith, Matthew Hunsinger, Andrew McKeown, et al.
Pain|September 19, 2012
Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: an ACTTION systematic reviewShannon M Smith, Daniel R Chang, Anthony Pereira, et al.
The Journal of Pain|February 10, 2015
Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic ReviewShannon M Smith, Florence Paillard, Andrew McKeown, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 5, 2014
Meta-analysis of assay sensitivity and study features in clinical trials of pharmacologic treatments for osteoarthritis painRobert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, et al.
Pain|November 27, 2013
Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendationsJennifer S Gewandter, Shannon M Smith, Andrew McKeown, et al.
Pageof 19